…HAYA Therapeutics, based in Switzerland, has partnered with Lilly, based in the United States, to discover genome targets for metabolic diseases. HAYA is set to receive up to $1 billion…
…find out which role they play in a particular health condition. In particular, Microbiotica is using its reference culture collection and genome database to develop medicines and diagnostic targets in…
…the generation of engineered ex vivo cell-based therapies, including genome editing approaches. But the limitations of current delivery modalities, both viral and non-viral, led Avectas to develop the non-viral SOLUPORE…
…at ASGCT the first demonstration that an engineered, modified tRNA could recognize and correct, in vivo, a flawed mRNA instruction no matter where it occurred in the genome. Alltrna, which…
…detectable. As a result, CRISPR is less efficient than TALEN when it comes to scaling up edited genomes so it will not be a satisfactory method when it comes to…
…the metagenome, which is the complete gene set of all different organisms in a given sample or within a given environment. Using the method, it is also possible to study…
…records were given to the press, and her genome was published online, which was then taken off soon after it had garnered backlash. In 2013, the Lacks family came to…
…that the new technique could provide a new approach to disease research and support the development of new therapies. Trim-Away acutely degrades endogenous proteins without modifying the genome or mRNA,…
…with the mission to improve ethnic diversity in collections of human genome sequences. At present, the majority of precision medicine research is based on genomic data from populations with European…
… Synthego. These guys are working on the edge of CRISPR genome engineering after building a bunch of rockets at SpaceX hand-in-hand with Elon Musk. What could be cooler…
…when it published that its pocket DNA sequencer designed for diagnostic purposes had sequenced the human genome. Meanwhile, liquid biopsies are already well-established in cancer diagnosis. Image via Kateryna Kon…
…in the human genome, and that’s the core of our target discovery efforts. Are AI and machine learning of any interest to you? Not really, it’s not in our core…